癌のリスクと従来の合成DMARDS:ナラティブレビュー
Thelma Skare1, Jozélio Freire de Carvalho2
1Department of Rheumatology, Hospital Evangélico Mackenzie, Curitiba, PR, Brazil.
Northern clinics of Istanbul
|August 22, 2025
まとめ
従来の疾患修正抗レウマティック薬 (DMARDs) は,レウマティック疾患を治療しますが,癌のリスクを増やす可能性があります. このレビューは,これらの広く使用されている免疫抑制剤と免疫調節剤の潜在的な発がん性を検討しています.
科学分野:
- リウマトロジ
- 腫瘍学
- 薬理学について
背景:
- 免疫抑制剤と免疫調節剤は,リウマチ病の管理に不可欠です.
- 従来の疾患修正抗レウマティック薬 (DMARD) には,メトトレキサート,アザチオプリン,抗マラリア薬,およびサイクロスポリンが含まれます.
- これらの治療は寛解を誘発し,炎症を制御し,患者の予後を改善することを目的としています.
研究 の 目的:
- 従来の疾患修正抗レウマ薬 (DMARD) の発がん性可能性に関する既存の文献をレビューする.
- 従来のDMARDの使用と悪性腫瘍の発症リスクとの関連を評価する.
- DMARDと癌のリスクに関する臨床医と研究者のための包括的な概要を提供する.
主な方法:
- ネラティブ・レビューの方法論が採用された.
- DMARDと癌を調査する研究のデータベースで文献検索が行われました.
- 従来のDMARDと悪性腫瘍のリスクに焦点を当てた関連する研究が合成されました.
主要な成果:
- 従来のDMARDは,特定の癌の潜在的なリスクの増加と関連しています.
- 特定のDMARDは,異なるレベルの発癌リスクを伴う可能性があります.
- DMARDと悪性腫瘍の複雑な関係を完全に解明するには,さらなる研究が必要です.
結論:
- リウマティック疾患の治療には有効ですが,従来のDMARDの腫瘍性可能性は慎重に検討する必要があります.
- これらの薬剤を処方する際にはリスク・利益の評価が不可欠です.
- 継続的なモニタリングと研究は 潜在的な副作用を軽減し,患者のケアを最適化するために不可欠です.
関連する概念動画
01:25Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
01:12Hazard Ratio
243
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
243
01:20The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231
01:19Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62